Web Analytics
LRMR (NASDAQ) 株価分析 | LARIMAR THERAPEUTICS INC – Deepscope
MARKET

Select Market Data Region

LRMR 株価分析 — Larimar Therapeutics Inc (Healthcare >> Biotechnology)

LRMR に関するよくある質問

LRMRのROE(自己資本利益率)は?

Larimar Therapeutics IncのROEは-105.04%です。

LRMRの配当利回りは?

Larimar Therapeutics Incの配当利回りは0.00%です。

LRMRの品質スコア(Quality Score)は?

当社のAIはLRMRの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

LRMRは今が買い時ですか?

当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

LRMRはどのセクターに属しますか?

Larimar Therapeutics IncはHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)

Stock Check   *Daily update data at 8:30 AM*
(Price: 2026-08-04 | FS: 2026-03-31)

LRMR AI Analysis Summary

Our AI summary for LRMR: Larimar Therapeutics Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -105.04%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

LRMR

Larimar Therapeutics Inc
USD 4.11
0.13 (3.27%) Day Change
0.01
D/E
-105.0%
ROE
-79.6%
ROA
0.00%
Div Yield
USD 4.11
Price
0.13 (3.27%)
Day Change
NEWS SCORE: 94

LRMR, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...

38

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Momentum indicators aligned on the daily timeframe
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...

Deepscope 分析 44%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 94
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 4.11
  PBV / Sector
2.62 / 44,022.72
  Earning Per Share -1.65
  PE / Sector
N/A / 19.17
  PEG or PE/Growth / Sector
N/A / 1.24
  Average 1M Daily Value
6.39 M
  Average 1W Daily Value
4.91 M
GREAT
Timing Factors 85%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ポイントになる統計 37%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
N/A / 98.24
  NPM Average (%) / Sector
N/A / -1,697.63
  NPM Change Average (%) / Sector
N/A / 5,097.97
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-79.61 / 185,260.96
  ROA Average (%) / Sector
-59.81 / 36,684.70
  ROA Change Average (%) / Sector
49.80 / 422,221.66
GREAT
  ROE (%) / Sector
-105.04 / 243,762.23
  ROE Average (%) / Sector
-88.03 / 48,758.47
  ROE Change Average (%) / Sector
88.05 / 424,968.10
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
配当 4%
X
  Dividend (%) / Sector
N/A / 0.04
  Dividend Average (%) / Sector
N/A / 17.04
  Dividend Change Average (%) / Sector
N/A / -0.49
登録情報
X
  Analyze Date 2026-08-05 08:00:29
  Symbol LRMR
  Name LARIMAR THERAPEUTICS INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 103.88 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 413.45 / 9,586.08
ニュース
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004

Phone: 844 511 9056

Website: https://www.larimartx.com

Employees: 71

Sector: Healthcare >> Biotechnology

Description: Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.

Analyst Ratings & Target Price

3 Months Ago
1 Month Ago
Current
Strong Buy
10
10
10
Buy
1
1
1
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
Consensus
Strong Buy 4.91
Strong Buy 4.91
Strong Buy 4.91
Target Price
USD 16.70
USD 14.40
USD 14.40

Per-Share Earnings, Estimates vs Actuals

Actual
Analyst Range
Estimate

ME vs SECTOR Healthcare >> Biotechnology

LRMR (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

同業種の銘柄

Healthcare › Biotechnology

同じ基準で分析・時価総額順

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
LRMR
LRMR
USD 4.11 (3.27%)
+ Watch + Port Chart